Neurocrine Biosciences (NBIX)

Neurocrine Biosciences (NBIX) – Analyst Comments

Mar 12, 2024 05:32 PM Neurocrine Bio. (NBIX) PT Raised to $200 at Oppenheimer, 'increasingly optimistic for NBIX's M4 agonist ahead of Ph2 topline results'
Jan 25, 2024 04:41 AM Neurocrine Bio. (NBIX) PT Raised to $153 at Goldman Sachs
Dec 19, 2023 07:27 AM
Aug 21, 2023 10:25 AM
Aug 21, 2023 06:19 AM
Jul 24, 2023 03:49 PM
Jul 24, 2023 06:22 AM
Mar 3, 2023 06:32 AM
Dec 13, 2022 09:57 AM
Oct 11, 2022 06:51 AM
Jun 6, 2022 08:08 AM
May 4, 2022 10:25 AM
May 4, 2022 10:24 AM
May 4, 2022 08:11 AM
Apr 26, 2022 05:57 AM
Mar 16, 2022 06:47 AM
Mar 3, 2022 06:07 AM
Feb 24, 2022 05:10 PM
Feb 14, 2022 08:55 AM
Feb 14, 2022 08:30 AM
Feb 14, 2022 05:51 AM
Feb 11, 2022 04:41 PM
Feb 11, 2022 11:44 AM
Feb 11, 2022 10:09 AM
Feb 11, 2022 08:19 AM
Feb 11, 2022 08:09 AM
Feb 1, 2022 06:24 AM
Jan 31, 2022 02:25 PM
Jan 18, 2022 06:39 AM
Jan 7, 2022 07:44 AM
Jan 7, 2022 06:22 AM
Dec 8, 2021 09:42 AM
Nov 23, 2021 07:22 AM
Nov 18, 2021 04:30 PM
Nov 17, 2021 03:33 AM
Oct 14, 2021 06:59 AM
Sep 22, 2021 04:11 PM
Aug 16, 2021 09:24 AM
Aug 3, 2021 05:54 PM
Jun 29, 2021 06:18 AM
May 18, 2021 06:49 AM
Mar 9, 2021 07:48 AM
Feb 19, 2021 06:06 AM
Feb 1, 2021 04:23 PM
Jan 12, 2021 06:23 AM
Oct 7, 2020 07:32 AM
Aug 4, 2020 09:10 AM
Aug 4, 2020 04:58 AM
Jun 29, 2020 06:04 AM
Jun 18, 2020 11:34 AM